Study of MB07811 in Subjects With Hypercholesterolemia

NCT00879112 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

80

Enrollment

INDUSTRY

Sponsor class

Stopped Study terminated prior to initiation

Conditions

Hypercholesterolemia

Interventions

DRUG: MB07811
DRUG: Placebo

Sponsor

Ligand Pharmaceuticals